Robert Place, Ph.D.

Robert Place
Co-Founder, CSO

Position type

Dr. Place has unparalleled expertise in the field of RNAa with an entrepreneurial background in biotech spanning nearly 10 years.  He was a key scientific lead working alongside Dr. Li during the initial discovery of RNAa and helmed the team collaboration between Alnylam Pharmaceutics, RNA Therapeutics, and University of California, San Francisco in the first efforts of RNAa drug development.  Dr. Place also played pivotal roles in the development of the nucleic acid capturing product line and oligonucleotide delivery platform at Sevident Inc.  Robert also served as Managing Director of discovery and early development to oversee non-clinical IND objectives and advise early-stage business strategy at Nova Therapeutics.